Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From current filing: Apollo Biowellness represents the consolidation of five cutting-edge companies (one of which, Evolutionary Biologics, Inc., is already a subsidiary of Emergent Health Corp.) operating in the regenerative medicine industry, each of them complimentary to one another, all having unique offerings or capabilities. The result is a new, vertically integrated player in the regenerative wellness category. By focusing on the three largest segments of the regenerative medicine market, we are positioned to become a leader in the fields of musculoskeletal care, wound healing and dermatology.
Apollo will, when its planned acquisitions of Juventix and IPS are completed, operate the following businesses through its subsidiaries:
? Integrative Practice Solutions, LLC, or IPS, organized under the laws of the state of Florida, engaged in licensing of The Advanced Arthritis Relief Protocol™, sale and distribution of medical devices, clinical training, and medical integration services. IPS is established as a leader in the non-surgical outpatient treatment of Osteoarthritis. It has developed America’s largest osteoarthritis treatment network with 200 licensed clinics in 37 states. With its highly profitable, disruptive technology, IPS has carved out a niche for its services that leaves it open to very limited competition;
? MAXIMUS Men’s Health, or Maximus, organized under the laws of the state of Delaware, focusing on solutions for the modern health focused male. The combination of osteoarthritis treatments, with PRP, and new age biologic products has enabled us to create treatments for uniquely male problems such as sports injuries, hair loss, erectile dysfunction, and testosterone replacement under Maximus.
? Juventix Regenerative Medical, LLC, organized under the laws of the state of Florida, is our state-of-the-art Platelet-Rich Plasma, or PRP, offering. We have created a futuristic processing procedure that sets Juventix apart from all competition in the PRP world. This world-class PRP offering allows us to have a door opener which “starts the conversation” with doctors interested in regenerative medicine.
Our Acquired Companies are expected to have a large, seasoned base of established customers.
IPS features 221 current licensees of its patented Advanced Arthritis Relief Protocol™, in 35 states. Additionally, IPS sells unloading knee braces, medical supplies, and other consumables to a total of 468 past and current customers. Juventix supplies PRP blood processing kits, medical devices, and supplies to over 500 healthcare clinics in the Shared States, as well as limited distribution internally (primarily in the Middle East).
Juventix and our already owned subsidiary, Evolutionary Biologics sell biologic products to doctors in many fields. Both companies utilize 1099 sales representatives to call directly on the doctors who are potential customers.
News: SCHEDULE 14C INFORMATION
Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934
(Amendment No. ___)
Check the appropriate box:
? Preliminary Information Statement
? Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2))
? Definitive Information Statement
Resonate Blends, Inc.
(Name of Registrant as Specified In Its Charter)
No they will operate as separate entities and Apollo (koan) will be the parent company
KOAN is the parent company Apollo of EMGE where do you see it going?
Any price target on KOAN?
Meet the CEO of Apollo https://apollobiowellness.com/month-in-review/
KOAN shall acquire all of the EMGE Equity Interests from the EMGE Preferred Shareholders by through the Exchange by issuance of the KOAN Exchange Shares." ?
All Equity interest from EMGE “preferred shareholders”
Don’t confuse that for common
KOAN which is now (Apollo) is the main parent.
Official 8k out closing
It’s official — 8K out on closing $KOAN $EMGE https://t.co/zzdxT25Fj3
— Resonate Blends (@Resonate_KOAN) March 20, 2024
KOAN Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
ACCESSWIRE 7 hrs ago 0
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holders of certain preferred stock of Emergent Health Corp. (OTC Pink:EMGE) ("Emergent Health" or "EMGE") (The "Agreement"), with the closing having taken place on March 14, 2024. Resonate Blends, the parent company, will become known as Apollo Biowellness, Inc. ("Apollo Biowellness"). The company is now located at One Marine Plaza, Suite 305A, North Bergen, NJ 04047.
The Company (to be known as Apollo Biowellness) is a holding company focused on regenerative medicine sold primarily to doctor's offices and clinics, as well as the public. The Company now consists of the following subsidiaries: Evolutionary Biologics, Integrative Practice Solutions LLC and Juventix Regenerative Medical LLC, and soon-to-be-launched Maximus Mean's Health.
The Company, as Apollo Biowellness, is a synergistic ecosystem of companies disrupting the next generation of the $5.6 trillion Global Health & Wellness Market. The global regenerative medicine market is currently at $20.04 billion in 2021 and predicted to be worth around $125.54 billion by 2030. We offer a one-stop solution for regenerative medicine with superior proprietary products and processes focused on the $1.1 trillion Personal Care, Beauty and Anti-Aging markets, with products sold through professional offices and directly to consumers. Our offerings include skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis and more. We foresee significant growth once we open DTC and OTC markets with FDA approval, which we will apply for, for skin care and hair growth products using human exosomes. We currently have a professional sales force with 700+ independent sales reps and distribution partners covering all aspects of our brand ecosystem. The company's subsidiaries will benefit from synergies in all backroom disciplines as well as sales & marketing and a seasoned collaborative management team.
Emergent Health Corp. will continue with the operations of Wholistic Brands, a majority-controlled subsidiary as a separate, but affiliated entity of the Parent Company, it is a brand that represents the best natural formulas made from plant-based ingredients, including shelf-stable plant-based exosomes. Wholistic is developing products in support of our suite of businesses while building a proprietary D2C and consumer business around clean wholistic health.
As part of the Agreement, Jim Morrison is the new Chairman of the Board of Directors and President/CEO of the Company. Morrison has stepped down as CEO/President of Emergent Health Corp. but will continue as Chairman of the Board of Directors of Emergent. The new management of Emergent will also be appointed and will report to the Board of the Company.
Jim Morrison is considered by many to be one of the leading personal care strategists in the world, as well as one of the top executives. Morrison was Chairman and President/CEO of Emergent Health Corp., a dynamic company in the wellness and regenerative biologics space. He has most recently been CEO of StarShop, which was the first celebrity-driven video shopping app, that was launched in partnership with SPRINT. His track record of leadership and accomplishment in the personal care products space has been unparalleled. Morrison was President of L'Oreal for over nine years. He was responsible for many acquisitions, including both Redken and Matrix, and top-line growth that averaged over 20% during his tenure. Prior to L'Oreal, Morrison was President and CEO of Graham Webb, one of the most successful startups in the hair care space. After leaving L'Oreal Morrison was CEO and owner of Sexy Hair Concepts for four years. In 2006, Business Week Magazine wrote, "Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry's history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the industry is unmatched."
As part of the transaction, the Company is conveying the previous assets of Resonate Blends to prior management.
About the former parent company Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is the former parent company, and as part of the transaction all the Intellectual Property and assets associated with it are being conveyed and transferred back to the former founding executive of Resonate Blends.
Apollo Biowellness is the new parent company and has no connection with the previous business of Resonate Blends.
ABOUT EMERGENT HEALTH CORP./Apollo Biowellness, Inc. (OTCMarkets Pink EMGE)
Emergent Health curates, develops and sells products in the regenerative health space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through "Content Based Shopping" using "Influencers" to successfully position products throughout the United States and Internationally. Evolutionary Biologics is a new kind of biologics company founded for a clear purpose: bring cutting-edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emergent's website.
Before using any of our products, you should always consult with your veterinarian and/or family doctor.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect the Company's business, including the business of any of its subsidiaries, is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.
Corporate Contact:
advertisement
MORE FROM THIS SECTION
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Missile targets ship off Yemen as rebels threaten wider campaign
Missile targets ship off Yemen as rebels threaten wider campaign
Across the US, batteries and green energies like wind and solar combine for major climate solution
Across the US, batteries and green energies like wind and solar combine for major climate solution
Jim Morrison
CEO/Director
jmorrison@evolutionarybiologics.com
www.emergenthealthcompany.com
203-253-9191
Contact Information:
Jim Morrison
President/CEO
jmorrison@evolutionarybiologics.com
2032539191
Jim Zimbler
President, Emergent Health
jzimbler@emergenthealthcompany.com
6318061420
SOURCE: Resonate Blends, Inc.
View the original press release on newswire.com.
advertisement
RECOMMENDED FOR YOU
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Nissan, Honda explore partnership in electric vehicles
Nissan, Honda explore partnership in electric vehicles
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Copyright 2024 ACCESSWIRE. All Rights Reserved.
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
×
Please enjoy a free sample of
koan - Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
ACCESSWIRE 7 hrs ago 0
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holders of certain preferred stock of Emergent Health Corp. (OTC Pink:EMGE) ("Emergent Health" or "EMGE") (The "Agreement"), with the closing having taken place on March 14, 2024. Resonate Blends, the parent company, will become known as Apollo Biowellness, Inc. ("Apollo Biowellness"). The company is now located at One Marine Plaza, Suite 305A, North Bergen, NJ 04047.
The Company (to be known as Apollo Biowellness) is a holding company focused on regenerative medicine sold primarily to doctor's offices and clinics, as well as the public. The Company now consists of the following subsidiaries: Evolutionary Biologics, Integrative Practice Solutions LLC and Juventix Regenerative Medical LLC, and soon-to-be-launched Maximus Mean's Health.
The Company, as Apollo Biowellness, is a synergistic ecosystem of companies disrupting the next generation of the $5.6 trillion Global Health & Wellness Market. The global regenerative medicine market is currently at $20.04 billion in 2021 and predicted to be worth around $125.54 billion by 2030. We offer a one-stop solution for regenerative medicine with superior proprietary products and processes focused on the $1.1 trillion Personal Care, Beauty and Anti-Aging markets, with products sold through professional offices and directly to consumers. Our offerings include skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis and more. We foresee significant growth once we open DTC and OTC markets with FDA approval, which we will apply for, for skin care and hair growth products using human exosomes. We currently have a professional sales force with 700+ independent sales reps and distribution partners covering all aspects of our brand ecosystem. The company's subsidiaries will benefit from synergies in all backroom disciplines as well as sales & marketing and a seasoned collaborative management team.
Emergent Health Corp. will continue with the operations of Wholistic Brands, a majority-controlled subsidiary as a separate, but affiliated entity of the Parent Company, it is a brand that represents the best natural formulas made from plant-based ingredients, including shelf-stable plant-based exosomes. Wholistic is developing products in support of our suite of businesses while building a proprietary D2C and consumer business around clean wholistic health.
As part of the Agreement, Jim Morrison is the new Chairman of the Board of Directors and President/CEO of the Company. Morrison has stepped down as CEO/President of Emergent Health Corp. but will continue as Chairman of the Board of Directors of Emergent. The new management of Emergent will also be appointed and will report to the Board of the Company.
Jim Morrison is considered by many to be one of the leading personal care strategists in the world, as well as one of the top executives. Morrison was Chairman and President/CEO of Emergent Health Corp., a dynamic company in the wellness and regenerative biologics space. He has most recently been CEO of StarShop, which was the first celebrity-driven video shopping app, that was launched in partnership with SPRINT. His track record of leadership and accomplishment in the personal care products space has been unparalleled. Morrison was President of L'Oreal for over nine years. He was responsible for many acquisitions, including both Redken and Matrix, and top-line growth that averaged over 20% during his tenure. Prior to L'Oreal, Morrison was President and CEO of Graham Webb, one of the most successful startups in the hair care space. After leaving L'Oreal Morrison was CEO and owner of Sexy Hair Concepts for four years. In 2006, Business Week Magazine wrote, "Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry's history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the industry is unmatched."
As part of the transaction, the Company is conveying the previous assets of Resonate Blends to prior management.
About the former parent company Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is the former parent company, and as part of the transaction all the Intellectual Property and assets associated with it are being conveyed and transferred back to the former founding executive of Resonate Blends.
Apollo Biowellness is the new parent company and has no connection with the previous business of Resonate Blends.
ABOUT EMERGENT HEALTH CORP./Apollo Biowellness, Inc. (OTCMarkets Pink EMGE)
Emergent Health curates, develops and sells products in the regenerative health space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through "Content Based Shopping" using "Influencers" to successfully position products throughout the United States and Internationally. Evolutionary Biologics is a new kind of biologics company founded for a clear purpose: bring cutting-edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emergent's website.
Before using any of our products, you should always consult with your veterinarian and/or family doctor.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect the Company's business, including the business of any of its subsidiaries, is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.
Corporate Contact:
advertisement
MORE FROM THIS SECTION
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Missile targets ship off Yemen as rebels threaten wider campaign
Missile targets ship off Yemen as rebels threaten wider campaign
Across the US, batteries and green energies like wind and solar combine for major climate solution
Across the US, batteries and green energies like wind and solar combine for major climate solution
Jim Morrison
CEO/Director
jmorrison@evolutionarybiologics.com
www.emergenthealthcompany.com
203-253-9191
Contact Information:
Jim Morrison
President/CEO
jmorrison@evolutionarybiologics.com
2032539191
Jim Zimbler
President, Emergent Health
jzimbler@emergenthealthcompany.com
6318061420
SOURCE: Resonate Blends, Inc.
View the original press release on newswire.com.
advertisement
RECOMMENDED FOR YOU
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Nissan, Honda explore partnership in electric vehicles
Nissan, Honda explore partnership in electric vehicles
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Copyright 2024 ACCESSWIRE. All Rights Reserved.
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
×
Please enjoy a free sample of
$KOAN Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
ACCESSWIRE 7 hrs ago 0
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holders of certain preferred stock of Emergent Health Corp. (OTC Pink:EMGE) ("Emergent Health" or "EMGE") (The "Agreement"), with the closing having taken place on March 14, 2024. Resonate Blends, the parent company, will become known as Apollo Biowellness, Inc. ("Apollo Biowellness"). The company is now located at One Marine Plaza, Suite 305A, North Bergen, NJ 04047.
The Company (to be known as Apollo Biowellness) is a holding company focused on regenerative medicine sold primarily to doctor's offices and clinics, as well as the public. The Company now consists of the following subsidiaries: Evolutionary Biologics, Integrative Practice Solutions LLC and Juventix Regenerative Medical LLC, and soon-to-be-launched Maximus Mean's Health.
The Company, as Apollo Biowellness, is a synergistic ecosystem of companies disrupting the next generation of the $5.6 trillion Global Health & Wellness Market. The global regenerative medicine market is currently at $20.04 billion in 2021 and predicted to be worth around $125.54 billion by 2030. We offer a one-stop solution for regenerative medicine with superior proprietary products and processes focused on the $1.1 trillion Personal Care, Beauty and Anti-Aging markets, with products sold through professional offices and directly to consumers. Our offerings include skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis and more. We foresee significant growth once we open DTC and OTC markets with FDA approval, which we will apply for, for skin care and hair growth products using human exosomes. We currently have a professional sales force with 700+ independent sales reps and distribution partners covering all aspects of our brand ecosystem. The company's subsidiaries will benefit from synergies in all backroom disciplines as well as sales & marketing and a seasoned collaborative management team.
Emergent Health Corp. will continue with the operations of Wholistic Brands, a majority-controlled subsidiary as a separate, but affiliated entity of the Parent Company, it is a brand that represents the best natural formulas made from plant-based ingredients, including shelf-stable plant-based exosomes. Wholistic is developing products in support of our suite of businesses while building a proprietary D2C and consumer business around clean wholistic health.
As part of the Agreement, Jim Morrison is the new Chairman of the Board of Directors and President/CEO of the Company. Morrison has stepped down as CEO/President of Emergent Health Corp. but will continue as Chairman of the Board of Directors of Emergent. The new management of Emergent will also be appointed and will report to the Board of the Company.
Jim Morrison is considered by many to be one of the leading personal care strategists in the world, as well as one of the top executives. Morrison was Chairman and President/CEO of Emergent Health Corp., a dynamic company in the wellness and regenerative biologics space. He has most recently been CEO of StarShop, which was the first celebrity-driven video shopping app, that was launched in partnership with SPRINT. His track record of leadership and accomplishment in the personal care products space has been unparalleled. Morrison was President of L'Oreal for over nine years. He was responsible for many acquisitions, including both Redken and Matrix, and top-line growth that averaged over 20% during his tenure. Prior to L'Oreal, Morrison was President and CEO of Graham Webb, one of the most successful startups in the hair care space. After leaving L'Oreal Morrison was CEO and owner of Sexy Hair Concepts for four years. In 2006, Business Week Magazine wrote, "Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry's history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the industry is unmatched."
As part of the transaction, the Company is conveying the previous assets of Resonate Blends to prior management.
About the former parent company Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is the former parent company, and as part of the transaction all the Intellectual Property and assets associated with it are being conveyed and transferred back to the former founding executive of Resonate Blends.
Apollo Biowellness is the new parent company and has no connection with the previous business of Resonate Blends.
ABOUT EMERGENT HEALTH CORP./Apollo Biowellness, Inc. (OTCMarkets Pink EMGE)
Emergent Health curates, develops and sells products in the regenerative health space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through "Content Based Shopping" using "Influencers" to successfully position products throughout the United States and Internationally. Evolutionary Biologics is a new kind of biologics company founded for a clear purpose: bring cutting-edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emergent's website.
Before using any of our products, you should always consult with your veterinarian and/or family doctor.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect the Company's business, including the business of any of its subsidiaries, is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.
Corporate Contact:
advertisement
MORE FROM THIS SECTION
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Missile targets ship off Yemen as rebels threaten wider campaign
Missile targets ship off Yemen as rebels threaten wider campaign
Across the US, batteries and green energies like wind and solar combine for major climate solution
Across the US, batteries and green energies like wind and solar combine for major climate solution
Jim Morrison
CEO/Director
jmorrison@evolutionarybiologics.com
www.emergenthealthcompany.com
203-253-9191
Contact Information:
Jim Morrison
President/CEO
jmorrison@evolutionarybiologics.com
2032539191
Jim Zimbler
President, Emergent Health
jzimbler@emergenthealthcompany.com
6318061420
SOURCE: Resonate Blends, Inc.
View the original press release on newswire.com.
advertisement
RECOMMENDED FOR YOU
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Nissan, Honda explore partnership in electric vehicles
Nissan, Honda explore partnership in electric vehicles
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Copyright 2024 ACCESSWIRE. All Rights Reserved.
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
×
Please enjoy a free sample of
News: Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
ACCESSWIRE 7 hrs ago 0
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holders of certain preferred stock of Emergent Health Corp. (OTC Pink:EMGE) ("Emergent Health" or "EMGE") (The "Agreement"), with the closing having taken place on March 14, 2024. Resonate Blends, the parent company, will become known as Apollo Biowellness, Inc. ("Apollo Biowellness"). The company is now located at One Marine Plaza, Suite 305A, North Bergen, NJ 04047.
The Company (to be known as Apollo Biowellness) is a holding company focused on regenerative medicine sold primarily to doctor's offices and clinics, as well as the public. The Company now consists of the following subsidiaries: Evolutionary Biologics, Integrative Practice Solutions LLC and Juventix Regenerative Medical LLC, and soon-to-be-launched Maximus Mean's Health.
The Company, as Apollo Biowellness, is a synergistic ecosystem of companies disrupting the next generation of the $5.6 trillion Global Health & Wellness Market. The global regenerative medicine market is currently at $20.04 billion in 2021 and predicted to be worth around $125.54 billion by 2030. We offer a one-stop solution for regenerative medicine with superior proprietary products and processes focused on the $1.1 trillion Personal Care, Beauty and Anti-Aging markets, with products sold through professional offices and directly to consumers. Our offerings include skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis and more. We foresee significant growth once we open DTC and OTC markets with FDA approval, which we will apply for, for skin care and hair growth products using human exosomes. We currently have a professional sales force with 700+ independent sales reps and distribution partners covering all aspects of our brand ecosystem. The company's subsidiaries will benefit from synergies in all backroom disciplines as well as sales & marketing and a seasoned collaborative management team.
Emergent Health Corp. will continue with the operations of Wholistic Brands, a majority-controlled subsidiary as a separate, but affiliated entity of the Parent Company, it is a brand that represents the best natural formulas made from plant-based ingredients, including shelf-stable plant-based exosomes. Wholistic is developing products in support of our suite of businesses while building a proprietary D2C and consumer business around clean wholistic health.
As part of the Agreement, Jim Morrison is the new Chairman of the Board of Directors and President/CEO of the Company. Morrison has stepped down as CEO/President of Emergent Health Corp. but will continue as Chairman of the Board of Directors of Emergent. The new management of Emergent will also be appointed and will report to the Board of the Company.
Jim Morrison is considered by many to be one of the leading personal care strategists in the world, as well as one of the top executives. Morrison was Chairman and President/CEO of Emergent Health Corp., a dynamic company in the wellness and regenerative biologics space. He has most recently been CEO of StarShop, which was the first celebrity-driven video shopping app, that was launched in partnership with SPRINT. His track record of leadership and accomplishment in the personal care products space has been unparalleled. Morrison was President of L'Oreal for over nine years. He was responsible for many acquisitions, including both Redken and Matrix, and top-line growth that averaged over 20% during his tenure. Prior to L'Oreal, Morrison was President and CEO of Graham Webb, one of the most successful startups in the hair care space. After leaving L'Oreal Morrison was CEO and owner of Sexy Hair Concepts for four years. In 2006, Business Week Magazine wrote, "Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry's history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the industry is unmatched."
As part of the transaction, the Company is conveying the previous assets of Resonate Blends to prior management.
About the former parent company Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is the former parent company, and as part of the transaction all the Intellectual Property and assets associated with it are being conveyed and transferred back to the former founding executive of Resonate Blends.
Apollo Biowellness is the new parent company and has no connection with the previous business of Resonate Blends.
ABOUT EMERGENT HEALTH CORP./Apollo Biowellness, Inc. (OTCMarkets Pink EMGE)
Emergent Health curates, develops and sells products in the regenerative health space. Its products comprise of ingestibles as well as topicals for the whole family. The company distributes its products online and through "Content Based Shopping" using "Influencers" to successfully position products throughout the United States and Internationally. Evolutionary Biologics is a new kind of biologics company founded for a clear purpose: bring cutting-edge regenerative products to the medical community. Emergent asserts that its products are not approved by the FDA to diagnose, treat, cure or prevent any disease(s). For more information, please visit Emergent's website.
Before using any of our products, you should always consult with your veterinarian and/or family doctor.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect the Company's business, including the business of any of its subsidiaries, is included in "Risk Factors" in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission.
Corporate Contact:
advertisement
MORE FROM THIS SECTION
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Afghan refugee stands trial in first of 3 killings that shocked Albuquerque's Muslim community
Missile targets ship off Yemen as rebels threaten wider campaign
Missile targets ship off Yemen as rebels threaten wider campaign
Across the US, batteries and green energies like wind and solar combine for major climate solution
Across the US, batteries and green energies like wind and solar combine for major climate solution
Jim Morrison
CEO/Director
jmorrison@evolutionarybiologics.com
www.emergenthealthcompany.com
203-253-9191
Contact Information:
Jim Morrison
President/CEO
jmorrison@evolutionarybiologics.com
2032539191
Jim Zimbler
President, Emergent Health
jzimbler@emergenthealthcompany.com
6318061420
SOURCE: Resonate Blends, Inc.
View the original press release on newswire.com.
advertisement
RECOMMENDED FOR YOU
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Things to know about Uber and Lyft saying they will halt ride-hailing services in Minneapolis
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Home sellers are cutting list prices as spring buying season starts with higher mortgage rates
Nissan, Honda explore partnership in electric vehicles
Nissan, Honda explore partnership in electric vehicles
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Apple to pay $490 million to settle allegations that it misled investors about iPhone sales in China
Copyright 2024 ACCESSWIRE. All Rights Reserved.
Facebook
Twitter
WhatsApp
SMS
Email
Copy article link
Save
×
Please enjoy a free sample of
Koan float under 32 million
Regenerative Medicine Market Set to Hit USD 194.9 Billion by 2032, Driven by Robust CAGR of 19.4%
https://finance.yahoo.com/news/regenerative-medicine-market-set-hit-123500909.html
$koan
Form 8-K - Current report
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 20, 2024
Resonate Blends, Inc.
(Exact name of registrant as specified in its charter)
Nevada 000-21202 58-1588291
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
26565 Agoura Road, Suite 200
Calabasas, CA
91302
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: 571-888-0009
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 1.01. Entry Into a Material Definitive Agreement.
On February 20, 2024, Resonate Blends, Inc. (the “Company”) entered into a Share Exchange Agreement (the “Exchange Agreement”) with Emergent Health Corp., a Wyoming corporation (hereinafter referred to as “EMGE”), and the holders (the “EMGE Preferred Shareholders) of Series Class A Preferred Stock, the Series C Convertible Non-Voting Preferred Stock and the Class F Preferred Stock of EMGE (the “EMGE Equity Interests”).
The Exchange Agreement provides that at the closing (the “Closing”), subject to the terms and conditions set forth in the Exchange Agreement, the EMGE Preferred Shareholders will exchange all of their respective EMGE Equity Interests for an equal number of issued and outstanding shares of preferred stock, of the Company, which will consist of a series of preferred stock that shall convert into 93% of the common stock of the Company on a fully diluted basis and the current shareholders of the Company owning approximately 7% of the fully-diluted capitalization of the Company, assuming certain convertible Company debt has converted at $0.035 per share, prior to Closing.
The Closing of the Exchange Agreement is subject to the satisfaction or, if permitted by applicable law, waiver, by the Company, EMGE, and the EMGE Preferred Shareholders, or all of various conditions. These conditions include, without limitation, (i) the Company shall have entered into a separate agreement for the sale of Resonate Blends, LLC and Entourage Labs, LLC to Geoffrey Selzer in exchange for a promissory note, (ii) $500,000 shall have been raised and payments made to prior counsel; and (iii) certain other customary conditions.
After Closing, the following actions are to be taken as stated in the Exchange Agreement:
? The current Board of Directors of the Company shall submit their respective resignations, and a new Board of Directors of the Company shall be installed by appointment or vote of shareholders.
? The new Board of Directors shall appoint new officers of the Company.
? The Company shall engage in a redomicile to the State of Delaware and reorganize pursuant to §251(g) of the Delaware General Corporation Law.
? Resonate Blends, LLC and Entourage Labs, LLC shall be sold to Geoffrey Selzer in exchange for a promissory note, with the amount currently in negotiation.
? A name change shall be effectuated amending the name of the Company.
$koan Form 8-K - Current report
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 20, 2024
Resonate Blends, Inc.
(Exact name of registrant as specified in its charter)
Nevada 000-21202 58-1588291
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
26565 Agoura Road, Suite 200
Calabasas, CA
91302
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: 571-888-0009
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 1.01. Entry Into a Material Definitive Agreement.
On February 20, 2024, Resonate Blends, Inc. (the “Company”) entered into a Share Exchange Agreement (the “Exchange Agreement”) with Emergent Health Corp., a Wyoming corporation (hereinafter referred to as “EMGE”), and the holders (the “EMGE Preferred Shareholders) of Series Class A Preferred Stock, the Series C Convertible Non-Voting Preferred Stock and the Class F Preferred Stock of EMGE (the “EMGE Equity Interests”).
The Exchange Agreement provides that at the closing (the “Closing”), subject to the terms and conditions set forth in the Exchange Agreement, the EMGE Preferred Shareholders will exchange all of their respective EMGE Equity Interests for an equal number of issued and outstanding shares of preferred stock, of the Company, which will consist of a series of preferred stock that shall convert into 93% of the common stock of the Company on a fully diluted basis and the current shareholders of the Company owning approximately 7% of the fully-diluted capitalization of the Company, assuming certain convertible Company debt has converted at $0.035 per share, prior to Closing.
The Closing of the Exchange Agreement is subject to the satisfaction or, if permitted by applicable law, waiver, by the Company, EMGE, and the EMGE Preferred Shareholders, or all of various conditions. These conditions include, without limitation, (i) the Company shall have entered into a separate agreement for the sale of Resonate Blends, LLC and Entourage Labs, LLC to Geoffrey Selzer in exchange for a promissory note, (ii) $500,000 shall have been raised and payments made to prior counsel; and (iii) certain other customary conditions.
After Closing, the following actions are to be taken as stated in the Exchange Agreement:
? The current Board of Directors of the Company shall submit their respective resignations, and a new Board of Directors of the Company shall be installed by appointment or vote of shareholders.
? The new Board of Directors shall appoint new officers of the Company.
? The Company shall engage in a redomicile to the State of Delaware and reorganize pursuant to §251(g) of the Delaware General Corporation Law.
? Resonate Blends, LLC and Entourage Labs, LLC shall be sold to Geoffrey Selzer in exchange for a promissory note, with the amount currently in negotiation.
? A name change shall be effectuated amending the name of the Company.
$koan Form 8-K - Current report
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 20, 2024
Resonate Blends, Inc.
(Exact name of registrant as specified in its charter)
Nevada 000-21202 58-1588291
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
26565 Agoura Road, Suite 200
Calabasas, CA
91302
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: 571-888-0009
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 1.01. Entry Into a Material Definitive Agreement.
On February 20, 2024, Resonate Blends, Inc. (the “Company”) entered into a Share Exchange Agreement (the “Exchange Agreement”) with Emergent Health Corp., a Wyoming corporation (hereinafter referred to as “EMGE”), and the holders (the “EMGE Preferred Shareholders) of Series Class A Preferred Stock, the Series C Convertible Non-Voting Preferred Stock and the Class F Preferred Stock of EMGE (the “EMGE Equity Interests”).
The Exchange Agreement provides that at the closing (the “Closing”), subject to the terms and conditions set forth in the Exchange Agreement, the EMGE Preferred Shareholders will exchange all of their respective EMGE Equity Interests for an equal number of issued and outstanding shares of preferred stock, of the Company, which will consist of a series of preferred stock that shall convert into 93% of the common stock of the Company on a fully diluted basis and the current shareholders of the Company owning approximately 7% of the fully-diluted capitalization of the Company, assuming certain convertible Company debt has converted at $0.035 per share, prior to Closing.
The Closing of the Exchange Agreement is subject to the satisfaction or, if permitted by applicable law, waiver, by the Company, EMGE, and the EMGE Preferred Shareholders, or all of various conditions. These conditions include, without limitation, (i) the Company shall have entered into a separate agreement for the sale of Resonate Blends, LLC and Entourage Labs, LLC to Geoffrey Selzer in exchange for a promissory note, (ii) $500,000 shall have been raised and payments made to prior counsel; and (iii) certain other customary conditions.
After Closing, the following actions are to be taken as stated in the Exchange Agreement:
? The current Board of Directors of the Company shall submit their respective resignations, and a new Board of Directors of the Company shall be installed by appointment or vote of shareholders.
? The new Board of Directors shall appoint new officers of the Company.
? The Company shall engage in a redomicile to the State of Delaware and reorganize pursuant to §251(g) of the Delaware General Corporation Law.
? Resonate Blends, LLC and Entourage Labs, LLC shall be sold to Geoffrey Selzer in exchange for a promissory note, with the amount currently in negotiation.
? A name change shall be effectuated amending the name of the Company.
8k out
$KOAN reverse merger Pegasus electric bus PR
Phoenix Motorcars Enters Electric School Bus Market with Order for 10 Zero Emission Buses from District of Columbia
Represents the Company’s initial order in the emerging and fast-growing electric school bus market
September 13, 2023 07:00 AM Eastern Daylight Time
ANAHEIM, Calif.--(BUSINESS WIRE)--Phoenix Motor Inc. (Nasdaq: PEV) (“Company” or “Phoenix”), a leader in manufacturing of all-electric, medium-duty vehicles, today announced a contract order for ten all electric, zero-emission Type-A school buses to be deployed from the Office of the State Superintendent of Education (OSSE). The contract was executed this summer and calls for the deployment of ten Phoenix school buses in the District of Columbia during 2024. The Phoenix Type-A School Buses will be built on Ford E-450 chassis powered by Phoenix’s 150-mile range battery electric drive system and a Pegasus Orion school bus body.
“The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District.”
Tweet this
“This is a vital first step to improving our carbon footprint and improving air quality in and around our schools and communities,” said State Superintendent Dr. Christina Grant. “The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District."
The Phoenix vehicles can be fully charged in less than two hours with a 100-kW Level III charger. The school buses, compared to their equivalent fossil fueled alternatives, can reduce atmospheric emissions by approximately 79 tons per vehicle annually, reduce maintenance costs by around 75% and lower fuel costs by approximately 80%.
“Phoenix is proud to be entering the electric school bus market. With this order, The District of Columbia is taking great steps to electrify its school bus fleet and cleaning the air quality near its students and in its communities,” Phoenix’s CEO Denton Peng said. “Our goal is to pave the way for the electrification of Type-A School Buses across America, and this project is a milestone for Phoenix Motorcars and our efforts to bring our leading electric drive system to every school district. We are committed to being the leader in zero emission Type-A School Buses and are excited to be partnered with Pegasus Specialty Vehicles.”
Phoenix has been the leader in medium-duty electrification for over a decade. With nearly 5 million all-electric miles driven on its zero-emission drive systems, Phoenix has extensive experience and expertise helping public and private fleets successfully deploy and adopt electric vehicles into their fleets, enhancing the air quality and providing clean, quiet and safe zero-emission transportation and mobility for their companies and communities.
“We couldn’t be happier to be able to partner with Phoenix Motorcars on this initial order for 10 Type-A school buses with Phoenix for the DC Schools,” said Pegasus President Brian Barrington. “We feel that utilizing our Orion body with the durable Phoenix EV drive system will be a great combination!”
$KOAN reverse merger Pegasus electric bus PR
Phoenix Motorcars Enters Electric School Bus Market with Order for 10 Zero Emission Buses from District of Columbia
Represents the Company’s initial order in the emerging and fast-growing electric school bus market
September 13, 2023 07:00 AM Eastern Daylight Time
ANAHEIM, Calif.--(BUSINESS WIRE)--Phoenix Motor Inc. (Nasdaq: PEV) (“Company” or “Phoenix”), a leader in manufacturing of all-electric, medium-duty vehicles, today announced a contract order for ten all electric, zero-emission Type-A school buses to be deployed from the Office of the State Superintendent of Education (OSSE). The contract was executed this summer and calls for the deployment of ten Phoenix school buses in the District of Columbia during 2024. The Phoenix Type-A School Buses will be built on Ford E-450 chassis powered by Phoenix’s 150-mile range battery electric drive system and a Pegasus Orion school bus body.
“The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District.”
Tweet this
“This is a vital first step to improving our carbon footprint and improving air quality in and around our schools and communities,” said State Superintendent Dr. Christina Grant. “The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District."
The Phoenix vehicles can be fully charged in less than two hours with a 100-kW Level III charger. The school buses, compared to their equivalent fossil fueled alternatives, can reduce atmospheric emissions by approximately 79 tons per vehicle annually, reduce maintenance costs by around 75% and lower fuel costs by approximately 80%.
“Phoenix is proud to be entering the electric school bus market. With this order, The District of Columbia is taking great steps to electrify its school bus fleet and cleaning the air quality near its students and in its communities,” Phoenix’s CEO Denton Peng said. “Our goal is to pave the way for the electrification of Type-A School Buses across America, and this project is a milestone for Phoenix Motorcars and our efforts to bring our leading electric drive system to every school district. We are committed to being the leader in zero emission Type-A School Buses and are excited to be partnered with Pegasus Specialty Vehicles.”
Phoenix has been the leader in medium-duty electrification for over a decade. With nearly 5 million all-electric miles driven on its zero-emission drive systems, Phoenix has extensive experience and expertise helping public and private fleets successfully deploy and adopt electric vehicles into their fleets, enhancing the air quality and providing clean, quiet and safe zero-emission transportation and mobility for their companies and communities.
“We couldn’t be happier to be able to partner with Phoenix Motorcars on this initial order for 10 Type-A school buses with Phoenix for the DC Schools,” said Pegasus President Brian Barrington. “We feel that utilizing our Orion body with the durable Phoenix EV drive system will be a great combination!”
Phoenix Motorcars Enters Electric School Bus Market with Order for 10 Zero Emission Buses from District of Columbia
Represents the Company’s initial order in the emerging and fast-growing electric school bus market
September 13, 2023 07:00 AM Eastern Daylight Time
ANAHEIM, Calif.--(BUSINESS WIRE)--Phoenix Motor Inc. (Nasdaq: PEV) (“Company” or “Phoenix”), a leader in manufacturing of all-electric, medium-duty vehicles, today announced a contract order for ten all electric, zero-emission Type-A school buses to be deployed from the Office of the State Superintendent of Education (OSSE). The contract was executed this summer and calls for the deployment of ten Phoenix school buses in the District of Columbia during 2024. The Phoenix Type-A School Buses will be built on Ford E-450 chassis powered by Phoenix’s 150-mile range battery electric drive system and a Pegasus Orion school bus body.
“The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District.”
Tweet this
“This is a vital first step to improving our carbon footprint and improving air quality in and around our schools and communities,” said State Superintendent Dr. Christina Grant. “The new electric buses will support our efforts to operate a cleaner and greener bus fleet in our community. We are grateful to Phoenix Motorcars and Pegasus Specialty Vehicles for their partnership in helping to better protect the health of children across the District."
The Phoenix vehicles can be fully charged in less than two hours with a 100-kW Level III charger. The school buses, compared to their equivalent fossil fueled alternatives, can reduce atmospheric emissions by approximately 79 tons per vehicle annually, reduce maintenance costs by around 75% and lower fuel costs by approximately 80%.
“Phoenix is proud to be entering the electric school bus market. With this order, The District of Columbia is taking great steps to electrify its school bus fleet and cleaning the air quality near its students and in its communities,” Phoenix’s CEO Denton Peng said. “Our goal is to pave the way for the electrification of Type-A School Buses across America, and this project is a milestone for Phoenix Motorcars and our efforts to bring our leading electric drive system to every school district. We are committed to being the leader in zero emission Type-A School Buses and are excited to be partnered with Pegasus Specialty Vehicles.”
Phoenix has been the leader in medium-duty electrification for over a decade. With nearly 5 million all-electric miles driven on its zero-emission drive systems, Phoenix has extensive experience and expertise helping public and private fleets successfully deploy and adopt electric vehicles into their fleets, enhancing the air quality and providing clean, quiet and safe zero-emission transportation and mobility for their companies and communities.
“We couldn’t be happier to be able to partner with Phoenix Motorcars on this initial order for 10 Type-A school buses with Phoenix for the DC Schools,” said Pegasus President Brian Barrington. “We feel that utilizing our Orion body with the durable Phoenix EV drive system will be a great combination!”
About OSSE
The Office of the State Superintendent of Education (OSSE) is the state education agency for the District of Columbia charged with raising the quality of education for all DC residents. OSSE serves as the District’s liaison to the US Department of Education and works closely with the District’s traditional and public charter schools to achieve its key functions, including: Overseeing all federal education programs and related grants administered in the District of Columbia; Developing state-level standards aligned with school, college, and workforce readiness expectations; Ensuring access to high-quality child care and universal pre-kindergarten for eligible District families; Providing resources and support to assist the District’s most vulnerable student populations; Administering the annual statewide student academic achievement exam; Providing regional, door-to-door transportation to school for District children with special needs; Awarding higher education financial assistance to eligible District students at public and private colleges and universities in DC and across the country; Increasing health and physical education awareness as well as ensuring access to free meals year-round; and many other functions. Visit osse.dc.gov to learn more.
About Phoenix Motor Inc.
Phoenix Motor Inc., a pioneer in the electric vehicle (“EV”) industry, designs, builds, and integrates electric drive systems and light and medium duty EVs and sells electric forklifts and electric vehicle chargers for the commercial and residential markets. Phoenix operates two primary brands, “Phoenix Motorcars”, which is focused on commercial products including medium duty EVs (shuttle buses, school buses, municipal transit vehicles and delivery trucks, among others), electric vehicle chargers and electric forklifts, and “EdisonFuture”, which intends to offer light-duty EVs. Phoenix endeavors to be a leading designer, developer and manufacturer of electric vehicles and electric vehicle technologies. For more information, please visit: www.phoenixmotorcars.com.
About Pegasus Specialty Vehicles
Pegasus Specialty Vehicles is spearheaded by industry-proven leadership, experienced as reputable expert innovators in the school transportation and manufacturing industries. Its management team brings a culture of creativity, flexibility, effectiveness, efficiency and teamwork to producing competitively priced modern school and shuttle buses that address market needs that have been ignored by existing bus manufacturers. Located in West Central Ohio, Pegasus is positioned to service the entire U.S. and Canada from one location. The company provides buses for both the school and transit bus industries. Pegasus Bus leadership is well recognized by bus dealers, school bus contractors, school district transportation operators, and decision-makers who have expressed dissatisfaction with current products that do not provide the features these buyers need and want. Learn more at www.ridepegasus.net
$KOAN news Resonate Blends Provides an Update on its Acquisition Partner Pegasus Specialty Vehicles
CALABASAS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Resonate Blends, Inc. (OTCQB: KOAN) ("Resonate") is pleased to
report an update on its acquisition partner Pegasus Specialty Vehicles, LLC ("Pegasus" or the "Company"). On June 23,
2023, Resonate announced the signing of an Agreement and Plan of Merger (the "Merger Agreement") with Pegasus and made a
$435,000 investment into the Ohio-based company. This investment, prior to the expected closing of this transaction, has
provided Pegasus with fresh capital to move forward on its ambitious revenue roadmap.
Pegasus is an innovative leader in the low-emission and zero-emission electric vehicle ("EV") and emerging hydrogen
fuel cell technology for school buses and specialty vehicles. Pegasus announced today they have shipped their first five
(5) buses with ten (10) more in various stages of completion. The Company currently has more than 100 chassis in their
production lot waiting for various components and the additional funding from Resonate to both close the Merger
Agreement and complete the production of the 100+ buses.
Included in their chassis inventory are the first four Peterbilt chassis with a demo school bus model nearly
completed. This represents Peterbilt's first foray into the school bus market and is being met with significant market
interest.
Pegasus is attending the STN Expo in Reno, Nevada this week showcasing their demo school bus and meeting with their
vast dealer network connections and various strategic partners.
Completion of the announced Merger Agreement is subject to the satisfaction of closing conditions that are to be
finalized as part of the Agreement. Accordingly, there can be no assurance that a closing will be consummated.
About Pegasus Specialty Vehicles, LLC
Pegasus Specialty Vehicles, LLC is a trailblazer in the technological evolution occurring within the School Bus
industry. Our management team has developed a clear strategy - and the infrastructure to support this transition, to
zero-emission solutions such as Electric and Hydrogen. The modular approach that we implement, alongside key established
partnerships with Peterbilt, Via Motors and Hyperion, enables us to meet current and future customer needs as the
industry adopts the new technologies, and provides tangible solutions to drive sustainable revenues and profits while
reducing market risk.
About Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is a Calabasas, CA-based portfolio of Cannabis Wellness and Lifestyle brands. The company created the
Resonate System--a comprehensive system of interconnected experience targets to personalize consumers' relationship with
Cannabis through its products. Koan Cordials, the world's first Cannabis Cordial and Resonate's flagship product line,
was awarded the prestigious Gold Leaf Award for "Best New Brand" and a Clio Cannabis award for packaging and design. To
learn more, please visit www.resonateblends.com
Forward-Looking Statements
$KOAN Resonate Blends Provides an Update on its Acquisition Partner Pegasus Specialty Vehicles
CALABASAS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Resonate Blends, Inc. (OTCQB: KOAN) ("Resonate") is pleased to
report an update on its acquisition partner Pegasus Specialty Vehicles, LLC ("Pegasus" or the "Company"). On June 23,
2023, Resonate announced the signing of an Agreement and Plan of Merger (the "Merger Agreement") with Pegasus and made a
$435,000 investment into the Ohio-based company. This investment, prior to the expected closing of this transaction, has
provided Pegasus with fresh capital to move forward on its ambitious revenue roadmap.
Pegasus is an innovative leader in the low-emission and zero-emission electric vehicle ("EV") and emerging hydrogen
fuel cell technology for school buses and specialty vehicles. Pegasus announced today they have shipped their first five
(5) buses with ten (10) more in various stages of completion. The Company currently has more than 100 chassis in their
production lot waiting for various components and the additional funding from Resonate to both close the Merger
Agreement and complete the production of the 100+ buses.
Included in their chassis inventory are the first four Peterbilt chassis with a demo school bus model nearly
completed. This represents Peterbilt's first foray into the school bus market and is being met with significant market
interest.
Pegasus is attending the STN Expo in Reno, Nevada this week showcasing their demo school bus and meeting with their
vast dealer network connections and various strategic partners.
Completion of the announced Merger Agreement is subject to the satisfaction of closing conditions that are to be
finalized as part of the Agreement. Accordingly, there can be no assurance that a closing will be consummated.
About Pegasus Specialty Vehicles, LLC
Pegasus Specialty Vehicles, LLC is a trailblazer in the technological evolution occurring within the School Bus
industry. Our management team has developed a clear strategy - and the infrastructure to support this transition, to
zero-emission solutions such as Electric and Hydrogen. The modular approach that we implement, alongside key established
partnerships with Peterbilt, Via Motors and Hyperion, enables us to meet current and future customer needs as the
industry adopts the new technologies, and provides tangible solutions to drive sustainable revenues and profits while
reducing market risk.
About Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is a Calabasas, CA-based portfolio of Cannabis Wellness and Lifestyle brands. The company created the
Resonate System--a comprehensive system of interconnected experience targets to personalize consumers' relationship with
Cannabis through its products. Koan Cordials, the world's first Cannabis Cordial and Resonate's flagship product line,
was awarded the prestigious Gold Leaf Award for "Best New Brand" and a Clio Cannabis award for packaging and design. To
learn more, please visit www.resonateblends.com
Forward-Looking Statements
News: Resonate Blends Provides an Update on its Acquisition Partner Pegasus Specialty Vehicles
CALABASAS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- Resonate Blends, Inc. (OTCQB: KOAN) ("Resonate") is pleased to
report an update on its acquisition partner Pegasus Specialty Vehicles, LLC ("Pegasus" or the "Company"). On June 23,
2023, Resonate announced the signing of an Agreement and Plan of Merger (the "Merger Agreement") with Pegasus and made a
$435,000 investment into the Ohio-based company. This investment, prior to the expected closing of this transaction, has
provided Pegasus with fresh capital to move forward on its ambitious revenue roadmap.
Pegasus is an innovative leader in the low-emission and zero-emission electric vehicle ("EV") and emerging hydrogen
fuel cell technology for school buses and specialty vehicles. Pegasus announced today they have shipped their first five
(5) buses with ten (10) more in various stages of completion. The Company currently has more than 100 chassis in their
production lot waiting for various components and the additional funding from Resonate to both close the Merger
Agreement and complete the production of the 100+ buses.
Included in their chassis inventory are the first four Peterbilt chassis with a demo school bus model nearly
completed. This represents Peterbilt's first foray into the school bus market and is being met with significant market
interest.
Pegasus is attending the STN Expo in Reno, Nevada this week showcasing their demo school bus and meeting with their
vast dealer network connections and various strategic partners.
Completion of the announced Merger Agreement is subject to the satisfaction of closing conditions that are to be
finalized as part of the Agreement. Accordingly, there can be no assurance that a closing will be consummated.
About Pegasus Specialty Vehicles, LLC
Pegasus Specialty Vehicles, LLC is a trailblazer in the technological evolution occurring within the School Bus
industry. Our management team has developed a clear strategy - and the infrastructure to support this transition, to
zero-emission solutions such as Electric and Hydrogen. The modular approach that we implement, alongside key established
partnerships with Peterbilt, Via Motors and Hyperion, enables us to meet current and future customer needs as the
industry adopts the new technologies, and provides tangible solutions to drive sustainable revenues and profits while
reducing market risk.
About Resonate Blends, Inc. (OTCQB:KOAN)
Resonate Blends is a Calabasas, CA-based portfolio of Cannabis Wellness and Lifestyle brands. The company created the
Resonate System--a comprehensive system of interconnected experience targets to personalize consumers' relationship with
Cannabis through its products. Koan Cordials, the world's first Cannabis Cordial and Resonate's flagship product line,
was awarded the prestigious Gold Leaf Award for "Best New Brand" and a Clio Cannabis award for packaging and design. To
learn more, please visit www.resonateblends.com
Forward-Looking Statements
Our acquisition partner, Pegasus Specialty Vehicles, will be showcasing its demo bus at the STN Expo West July 14-19, 2023 in Reno, Nevada. Pegasus is working on some exciting developments!
#STNExpo #Bus #Reno #cleanenergy. #EV #hydrogen $KOAN
Our acquisition partner, Pegasus Specialty Vehicles, will be showcasing its demo bus at the STN Expo West July 14-19, 2023 in Reno, Nevada. Pegasus is working on some exciting developments!#STNExpo #Bus #Reno #cleanenergy. #EV #hydrogen $KOAN pic.twitter.com/NCQP0ElVW5
— Resonate Blends (@Resonate_KOAN) July 12, 2023
300% run up vs 30% correction filling the gap. Hilarious thanks for the warning
DUNKIRK, Ohio — Pegasus Specialty Vehicles is announcing Hudson Bus Sales of Cleburne, Texas has submitted a purchase order for 200 Pegasus Valkyrie MFSAB’s with the new VIA Motors, a division of Ideanomics, VTrux platform. This is the first order commitment from a dealer from the 2,000 chassis commitment Pegasus made with VIA Motors.
“I am extremely happy that Hudson Bus has made the commitment to the VIA chassis with Pegasus. We hear a lot in the industry about vertically integrated and the such, we prefer purpose built. VIA provides a chassis that is purpose built from the ground up to be EV. It provides us with a great platform at a great price point” according to Pegasus President Brian Barrington. “Obviously we feel very strong that this chassis will set the standard, in terms of performance and reliability.”
The VIA chassis is set to begin production in 2024 and the Hudson Bus Sales units will be the first production, purpose built EV MFSAB.
About Pegasus Specialty Vehicles
Pegasus Specialty Vehicles is spearheaded by industry-proven leadership, experienced as reputable expert innovators in the school transportation and manufacturing industries. Its management team brings a culture of creativity, flexibility, effectiveness, efficiency, and teamwork to producing competitively priced modern school and shuttle buses that address market needs that have been ignored by existing bus manufacturers. Located in West Central Ohio Pegasus is positioned to be able to service the entire U.S. and Canada from one location. The company provides buses for both school and transit bus industries. The company’s leadership is well recognized by bus dealers, school bus contractors, school district transportation operators, and decision-makers who have expressed dissatisfaction with current products that do not provide the features these buyers need and want. Learn more at http://www.ridepegasus.net/.
* KOAN signs definitive LOI to merge w/ Electric Bus and shuttle company Pegasus. Valuation is $60 million current stock value is only $6 million
Over 200 buses currently on order
Do your DD where this is going
$KOAN signs definitive LOI to merge w/ Electric Bus and shuttle company Pegasus. Valuation is $60 million current stock value is only $6 million
Over 200 buses currently on order
Do your DD where this is going
KOAN signs definitive LOI to merge w/ Electric Bus and shuttle company Pegasus. Valuation is $60 million current stock value is only $6 million
Over 200 buses currently on order
Do your DD where this is going
Pegasus Bus Introduces Innovative Atlas Models, Using Peterbilt Chassis for Transit and School Bus Applications
Share Article
Pegasus’ new Atlas models usher in new competition for transit and paratransit buses in the public transportation sector and Type A and Type C vehicles in the school bus market.
DUNKIRK, OHIO (PRWEB) JULY 27, 2022
Pegasus Bus Company, a Dunkirk, Ohio-based company spearheaded by veterans in the school and transit bus industries, announced details surrounding the design of its all-new Atlas models today. The advanced, feature-rich Atlas bodies will be built for shuttle, paratransit and Type A school buses on the Peterbilt 535 chassis, and for shuttle, paratransit and Type C school buses on the Peterbilt 536 and 537 chassis. At 48 seats, the Pegasus Type A school bus will offer the most seating of any bus in its class. Pegasus does business in the U.S. and Canada and will introduce the first Pegasus Type C school bus, which is expected in November 2022.
With their unique body designs and state-of-the-art standard features and options, the new Pegasus vehicles will give bus buyers greater freedom of choice. The broad availability of Atlas models through the Pegasus dealer network will enhance competitiveness that should broadly benefit transit and school bus players in much of North America.
“Pegasus’ primary strategic objective is predicated upon bringing new, innovative and unique bus solutions to the marketplace, and our Atlas models are the culmination of our initial work,” said Brian Barrington, president of Pegasus Bus Company. “Our advanced bodies mounted on these reliable, fuel-efficient and customizable chassis will truly be a game-changer in the markets we’re focusing on.”
With its galvanized steel cage construction, aluminum skins and one-piece, five-eighth-inch corrosion-resistant composite floor, the Pegasus Atlas is designed with durability and functionality in mind. While other bus manufacturers regularly compromise by using traditional plywood floors and invite rot and corrosion by bolting seats directly to and through them, the Atlas’ seats are track-mounted to the vehicle’s waterproof polymer floor. Because there are no wheel wells on the Atlas, the seats are able to be fully adjustable, providing users with greater flexibility. Seats from IMMI come with lap belt restraints standard, and seats with three-point restraints are optional.
The Atlas body’s generous 92-inch width allows for 14-inch-wide aisles, promoting easier maneuverability for children and drivers. The Atlas’ spacious 75-inch standard ceiling height can also be extended to 78 inches if desired.
The ample 34-inch-wide by 88-inch-tall entrance doors of the Pegasus Atlas are electronically controlled. The entrance door’s push-button operation reduces a driver’s exposure to the fatigue and the type of shoulder and arm strains often associated with repetitive manual door operation. Step wells are fully clad in stainless steel with diamond tread for superior traction.
Advanced LED interior and exterior lighting is standard on the Atlas, greatly reducing the possibility of lighting failures and the need to replace lamps. The vehicles also come with a full conspicuity tape package already applied. Windows come tinted with black frames standard, keeping bus interiors cooler and more comfortable and giving the vehicle’s exterior a clean finish.
The Atlas news comes on the heels of other significant announcements from Pegasus. The company recently placed its first order with Zeus Electric Chassis. Pegasus will use the Zeus Z-19 Power Platform to deliver shuttle and paratransit buses that they say will be categorically different from any gas or diesel conversions available today. The ground-up design of the Zeus Z-19 cab and chassis is purpose-built and optimized for bus body installation and system integration.
Pegasus also recently announced details of a newly penned agreement with the nation’s largest bus dealership, Creative Bus Sales. With 23 locations in the U.S., the deal with Creative Bus Sales will enable Pegasus to capture opportunities and win a portion of the abundant federal and state grant money incentivizing rapid electric-bus adoption. Now, with the addition of new Pegasus buses built on the Peterbilt 535, 536 and 537 chassis, Creative Bus Sales’ nationwide distribution footprint and deep market penetration, and the unique diesel, natural gas and electric bus offerings from Pegasus, the company is well positioned to compete.
“We’re very excited to help take the new Pegasus Type A school buses and their shuttle, paratransit and Type C school buses to market,” said Jason Hohalok, sales manager for California for Creative Bus Sales. “The Atlas offers innovative new body solutions on three very reliable Peterbilt platforms and we think our customers will be very receptive.”
To access high-resolution product images of Pegasus buses on multiple vehicle platforms, please visit https://www.ridepegasus.net/new-page.
END -
About Pegasus Bus Company
Pegasus Bus Company is spearheaded by industry-proven leadership, experienced as reputable expert innovators in the school transportation and manufacturing industries. Its management team brings a culture of creativity, flexibility, effectiveness, efficiency and teamwork to producing competitively priced modern school and shuttle buses that address market needs that have been ignored by existing bus manufacturers. Located in West Central Ohio Pegasus is positioned to be able to service the entire U.S. and Canada from one location. The company provides buses for both school and transit bus industries. Pegasus Bus leadership is well recognized by bus dealers, school bus contractors, school district transportation operators, and decision-makers who have expressed dissatisfaction with current products that do not provide the features these buyers need and want. Learn more at http://www.ridepegasus.net
KOAN tweets “(1) $KOAN was presented opportunities to merge with several intriguing companies. With our solid capital structure, fully-reporting status & loyal investor base, we were an attractive pubco option. Pegasus Speciality Vehicles was the clear choice.”
“(2) Pegasus has an experienced leadership team, strong industry connections, IP/innovation & a robust revenue roadmap in an emerging #EV & #hydrogen school #bus & speciality vehicle market. We feel this is a tremendous opportunity for our shareholders. $KOAN #cleanenergy #merger”
Trading nicely filling in the gap at 8
Watch what ASCM does on level 2 when they get outbid. Short the offer look to cover the bid.
They will want to maintain top bid to cover the shares they are shorting on the offer.
Wrong this is what’s happening what you falsely call dilution and it’s mms using their exemptions to short
“ASCM is the most popular market maker for shorting stocks and create a scare when there in the ask and can. be a resistance level. ASCM often appears on very volitate stocks that made a nice move and ASCM looks to short for the price per share correction. When ASCM appears on the bid side close to the price level it means they're covering their position. In order to cover they need to buy back the shares they shorted so it often provides an area of support.”